All In MedTech

Device Trial Radar · NCT02676479

Uterine Irrigation Method in Infertility Patients Who Require PGD

The Histological and Genetic Investigation of Cells, Fluid and Tissue in the Uterine Cavity, Using the Uterine Irrigation Method, in Patients Who Suffer From Unexplained Infertility and Hereditary Genetic Disease, and Who Require PGD Scans.

Last checked: Nov 20, 2026Latest source record: Jun 1, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

30

Planned (sponsor's estimate)

Start

Feb 2016

Primary completion

Sep 2016

Study completion Dec 2016

Sponsor

Lead sponsor
Istanbul UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Previvo Genetics; Acibadem Fulya Hospital
First posted
Feb 8, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
Female only, from 21 years, up to 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will involve up to 30 pairs of male and female sexually intimate partners who are carriers for a genetic disease (e.g Sickle Cell Disease or Thalassemia) and at high risk of transmitting the gene. The female partner will be superovulated to mature multiple oocytes which can be fertilized, inseminated with her partner's sperm through intra-uterine insemination (IUI). Four to six days after IUI, the female partner will undergo a non-surgical uterine lavage procedure to recover preimplantation embryos.

Conditions

  • Pre-Implantation Embryo Recovery
  • Genetic Diseases, Inborn

Interventions

  • Uterine Lavage GroupDevice

    The PI places the Lavage Catheter per instructions for use * Use of a tenaculum or cervical stitch is required * Use of saline to wash the cervix is required * Use of abdominal ultrasound guidance with a full bladder is required The PI records if there was clinically significant fluid loss through the cervix.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blastocyst RetrievalTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Istanbul University School of Medicine

    Istanbul, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.